相关实验视频

Updated: Jan 10, 2026

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

[一个结合小细胞肺癌的案例和文献评论]

Minglang Gao¹, Xiao Lu¹, Bo Hao¹

¹Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.

Zhongguo fei ai za zhi = Chinese journal of lung cancer

|November 27, 2025

概括

结合性小细胞肺癌 (CSCLC) 是一种罕见的SCLC亚型,与NSCLC混合. 这项研究审查了CSCLCLC.

科学领域:

在瘤学瘤学.
肺部病理学肺部病理学
病理学病理学病理学

背景情况:

结合性小细胞肺癌 (CSCLC) 是一种罕见的小细胞肺癌 (SCLC) 亚型,其特征是SCLC和非小细胞肺癌 (NSCLC) 组件的混合.
CSCLC被归类为神经内分泌瘤,但研究主要集中在纯SCLC上,使CSCLC研究不足.
CSCLC的罕见性和异质性导致缺乏标准化的治疗方案和对其临床病理特征和预后指标的统一理解.

研究的目的:

报告一种罕见的结合小细胞肺癌 (CSCLC) 病例的治疗过程.
提供关于CSCLC当前研究状况的综合文献综述.
突出需要对CSCLC的疗效和预后进行进一步的研究.

主要方法:

病例报告详细介绍了诊断为CSCLC的患者的治疗方法.
对现有关于CSCLC的研究进行系统的文献审查.
从案例和文献中分析临床病理特征和治疗结果.

主要成果:

病例报告说明了CSCLC的临床管理.
文献综述显示,与纯SCLC相比,关于CSCLC的研究存在重大差距.
目前对CSCLC临床病理特征和预后因素的理解仍然有限.

结论:

结合性小细胞肺癌 (CSCLC) 由于其稀有性和独特的临床特征,需要进一步的专门研究.
目前,CSCLC缺乏标准化的诊断标准和治疗策略.
需要进行额外的研究来阐明CSCLC的疗效和预后,以改善患者的治疗结果.

关键词:

案例报告案例报告结合小细胞肺癌的结合性肺癌.文献综述文献综述文献综述肺部瘤是什么意思状细胞癌瘤是一种状细胞癌.

更多相关视频

Acellular and Cellular Lung Model to Study Tumor Metastasis

Acellular and Cellular Lung Model to Study Tumor Metastasis

Published on: August 19, 2018

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...